The Division for Translational and Clinical Pharmacology (TCP) serves to reflect the changing landscape of the field and embrace the diversity of its members. TCP strives to provide career development and trainee mentorship for all pharmacologists attempting to integrate their experimental results and translate them for the benefit of health. Scientists with diverse research interests might be expected to find a home in this highly relevant and dynamic division.
- To promote the translation of basic research to clinical utility (Bedside-to-Bench-to-Bedside)
- To foster the improvement of individualized healthcare and drive the discovery of new medicines to treat and cure diseases
- To provide resources, mentorship and opportunities for junior members (in particular undergraduate and graduate students, postdoctoral researchers and junior faculty)
- To organize Symposia on topics relevant to the mission of the Division and to the ASPET membership at large
- To highlight members’ research accomplishments and promote collaboration between academia, industry, and government
- To foster connections between the Division for Translational and Clinical Pharmacology and other ASPET divisions and FASEB societies
Posting on social media about the TCP division? Use #ASPETTCP.
August 08, 2019
On June 7, 2019 it was announced by Buckingham Palace that Her Majesty Queen Elizabeth II had appointed Professor V. Craig Jordan, OBE as Companion of the Most Distinguished Order of St. Michael and St. George (CMG) for services to women’s health.
July 08, 2019
ASPET will be hosting a “Division Takeover” from mid-July through October. During this time, our divisions will have a week where they’ll feature prominently in our social media posts.
July 01, 2019
The ASPET Division for Translational and Clinical Pharmacology is pleased to announce that nominations are now being accepted for the 2020 ASPET Awards.
Last Updated: June 6, 2019